Health Affairs June 25, 2020
Kao-Ping Chua, Rena M. Conti

According to our search of studies registered on clinicaltrials.gov as of April 20, 2020, many drugs being evaluated to treat or prevent COVID-19 have orphan drug designation (exhibit 1). We will explain...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, FDA, Govt Agencies, Healthcare System, Pharma, Pharma / Biotech, Public Health / COVID
Will Synthetic, AI-Based Digital Humans Change Pharma and Life Sciences? Q&A with Abid Rahman, SVP Innovation, EVERSANA
Cerevel Parkinson’s data adds lustre to AbbVie acquisition
Roche Drug Scores Label Expansion for Earlier Use in Lung Cancer
Pharma Pulse 4/19/24: The Health and Healthcare of Gen-Z, Long-Acting Drugs May Revolutionize HIV Prevention/Treatment & more
Recursion, Canaan, Metsera and more—Chutes & Ladders

Share This Article